Utility of exhaled nitric oxide in the diagnosis and management of asthma.

  • Majid H
  • Kao C
  • 6


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


PURPOSE OF REVIEW: The fraction of nitric oxide in exhaled air (FeNO) is elevated in the presence of airway inflammation, and it may be a useful biomarker in asthma. The purpose of the present review is to highlight the current literature investigating the use of exhaled nitric oxide in the diagnosis and management of asthma. RECENT FINDINGS: The measurement of exhaled nitric oxide has been studied in normal populations and in asthmatics. FeNO appears to be a useful screening tool for asthma, although nondisease factors may confound the interpretation of an elevated FeNO level. Clinical trials investigating the use of FeNO measurements in predicting asthma exacerbation and tailoring maintenance therapy have had varying success. Further studies incorporating individualized FeNO profiles into treatment algorithms are needed. SUMMARY: FeNO shows promise as a tool in the diagnosis and treatment of asthma. However, further studies are needed to address outstanding questions about its exact role in guiding asthma management.

Author-supplied keywords

  • 16
  • 42
  • 47
  • asthma
  • curr opin pulm med
  • diagnosis
  • fraction of nitric oxide
  • health
  • in exhaled air
  • lippincott williams
  • management
  • wilkins
  • ß 2010 wolters kluwer

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in


  • Hashir Majid

  • Christina Kao

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free